Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats


Autoria(s): Steagall, P. V. M.; Carnicelli, P.; Taylor, P. M.; Luna, Stélio Pacca Loureiro; Dixon, M.; Ferreira, T. H.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/12/2006

Resumo

This study compared pressure and thermal thresholds after administration of three opioids in eight cats. Pressure stimulation was performed via a bracelet taped around the forearm. Three ball-bearings were advanced against the forearm by inflation of a modified blood pressure bladder. Pressure in the cuff was recorded at the end point (leg shake and head turn). Thermal threshold was tested as previously reported using a heated probe held against the thorax [Dixon et al. (2002) Research in Veterinary Science, 72, 205]. After baseline recordings, each cat received subcutaneous methadone 0.2 mg/kg, morphine 0.2 mg/kg, buprenorphine 0.02 mg/kg or saline 0.3 mL in a four period cross-over study. Measurements were made at 15, 30, 45 min and 1, 2, 3, 4, 8, 12 and 24 h after the injection. Data were analysed by ANOVA (P < 0.05). There were no significant changes in thresholds after saline. Thermal threshold increased at 45 min after buprenorphine (maximum 2.8 +/- 3 degrees C), 1-3 h after methadone (maximum 3.4 +/- 1.9 degrees C) and 45 min to 1 h (maximum 3.4 +/- 2 degrees C) after morphine. Pressure threshold increased 30-45 min (maximum 238 +/- 206 mmHg) after buprenorphine, 45-60 min after methadone (maximum 255 +/- 232 mmHg) and 45-60 min and 3-6 h (maximum 255 +/- 232 mmHg) after morphine. Morphine provided the best analgesia, and methadone appears a promising alternative. Buprenorphines limited effect was probably related to the subcutaneous route of administration. Previously, buprenorphine has produced much greater effects when given by other routes.

Formato

531-537

Identificador

http://dx.doi.org/10.1111/j.1365-2885.2006.00800.x

Journal of Veterinary Pharmacology and Therapeutics. Oxford: Blackwell Publishing, v. 29, n. 6, p. 531-537, 2006.

0140-7783

http://hdl.handle.net/11449/10884

10.1111/j.1365-2885.2006.00800.x

WOS:000241737700010

Idioma(s)

eng

Publicador

Blackwell Publishing

Relação

Journal of Veterinary Pharmacology and Therapeutics

Direitos

closedAccess

Tipo

info:eu-repo/semantics/article